Date,Ticker,Snippit,W/L?,%Change
2017-12-03,ABBV,Cornercap Investment Counsel Has Raised Abbvie Com (ABBV) Stake; Profile of 7 Analysts ... NormanObserver.com The firm also develops,,
2017-12-01,ABBV,AbbVie Inc. (NYSE:ABBV) Updates On Phase III Murano Trial MMJ Reporter AbbVie Inc. (NYSE:ABBV) reported that the American Society of,,
2017-11-30,ACAD,EPS for The Kroger Co. (KR) Expected At $0.41; Acadia Pharmaceuticals (ACAD)&#39;s Sentiment Is 1.05 San Times The Company&#39;s,,
2017-12-02,ALNY,How Analysts Rated Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Last Week? BZ Weekly The companyÂ&#39;s clinical development programs,,
2017-12-03,ARGX,ASH: Here&#39;s Why You Need To Keep An Eye On ARGX MGNX KURA AGIO Nasdaq argenx&#39;s lead oncology asset is ARGX-110 currently,,
2017-12-02,BABA,Tiger Legatus Capital Management Cut Alibaba Group Hldg LTD (BABA) Position By $2.80 Million ... UtahHerald.com The companyÂ&#39;s,,
2017-12-01,BAYN,Bayer unblinds prostate cancer combo trial early due to AEs The Pharma Letter German pharma major Bayer (BAYN: DE) this morning,,
2017-12-03,BPMX,BioPharmX Corporation (BPMX) EPS Estimated At $-0.06 WeeklyHub The Company&#39;s clinical-stage product candidates include BPX03 a,,
2017-12-02,CISN,Cision Ltd. (CISN) Reaches $11.75 After 3.00% Up Move; ARGOS THERAPEUTICS (ARGS)&#39;s ... Herald KS The Company&#39;s product,,
2017-12-03,CLSN,Celsion Corporation (CLSN) Sees Significant Decrease in Short Interest Dispatch Tribunal Celsion logo Celsion Corporation (NASDAQ:,,
2017-12-03,CLSN,Celsion (NASDAQ:CLSN) Coverage Initiated by Analysts at Oppenheimer TrueBlueTribune Celsion logo Stock analysts at Oppenheimer,,
2017-12-02,CLSN,Short Interest in Celsion Corporation (CLSN) Increases By 93.7% The Lincolnian Online Celsion logo Celsion Corporation (NASDAQ:CLSN),,
2017-12-01,CLSN,Celsion (NASDAQ:CLSN) Downgraded by ValuEngine StockNewsTimes Celsion Corporation logo ValuEngine lowered shares of Celsion (NASDAQ:,,
2017-12-01,CLSN,Celsion (NASDAQ:CLSN) Issues Earnings Results Misses Estimates By $0.14 EPS StockNewsTimes Celsion logo Celsion (NASDAQ:CLSN) posted,,
2017-11-29,CLSN,Celsion (NASDAQ:CLSN) Issues Earnings Results The Ledger Gazette Celsion logo Celsion (NASDAQ:CLSN) announced its earnings results,,
2017-12-03,CSX,CSX (CSX) Stock “Buy” Rating Reconfirmed at UBS; The Target is $68.0; 17 Bullish Analysts ... HuronReport The Company&#39;s products,,
2017-11-29,EARS,EARS Pinched By HEALOS Data EGLT Does It Again JAVELIN Gastric 300 Misses Mark Nasdaq (RTTNews.com) - Today&#39;s Daily Dose,,
2017-12-03,GERN,Geron (GERN) and Sangamo Therapeutics (NASDAQ:SGMO) Financial Analysis Dispatch Tribunal Janssen is engaged in the development of,,
2017-12-02,MDXG,MiMedx Group Inc. (MDXG) Is At $11.56 Formed Wedge; Cytrx (CYTR) Shorts Decreased By 2.98% HuronReport The companyÂ&#39;s product,,
2017-11-30,MRK,Merck (MRK) Announces New Updated Data for its KEYTRUDA and Updated Data on LYNPARZA ... StreetInsider.com KEYTRUDA presentations,,
2017-11-29,MRK,Merck and Pfizer&#39;s Checkpoint Inhibitor Fails to Treat Gastric Cancer Labiotech.eu (blog) Avelumab marketed as Bavencio by,,
2017-12-01,NTNX,Nutanix (NTNX) PT Raised to $51 at Maxim Group StreetInsider.com Analyst Nehal Chokshi comments &quot;Plinabulin itself is a platform,,
2017-12-02,OCRX,Analyzing Ocera Therapeutics (OCRX) and Argos Therapeutics (ARGS) The Ledger Gazette It is conducting a pivotal Phase III clinical,,
2017-12-03,OMER,Omeros Corp (NASDAQ:OMER) 2017 Q2 Sentiment Change BZ Weekly The Company&#39;s clinical programs include OMS721 that is in Phase III,,
2017-12-01,PAIOF,PAION AG AACHEN (OTCMKTS:PAIOF) Shorted Shares Decreased By 1.03% BZ Weekly on October 27 2014 also Businesswire.com with their,,
2017-12-01,PLX,Protalix Biotherapeutics Incorporated (NYSEAMERICAN:PLX) Sellers Increased By 1.61% Their ... BZ Weekly The Company&#39;s product,,
2017-12-02,PTCT,Head-To-Head Comparison: PTC Therapeutics (NASDAQ:PTCT) and Vital Therapies (VTL) Week Herald The Company initiated a Phase III,,
2017-12-02,RTRX,Is Retrophin Incorporated (NASDAQ:RTRX)&#39;s Fuel Running High? Reports Show Less Sellers BZ Weekly The companyÂ&#39;s product,,
2017-12-03,SGEN,Seattle Genetics Incorporated (NASDAQ:SGEN)&#39;s Trend Up Especially After Decreased Shorts BZ Weekly The firm also develops SGN-,,
2017-12-01,SNDX,Syndax Pharmaceuticals Inc. (SNDX) Reaches $8.40 After 7.00% Down Move; BSB Bancorp ... UtahHerald.com The companyÂ&#39;s lead,,
2017-12-01,SNY,Sanofi (SNY) Ends Development of Clostridium Difficile Vaccine StreetInsider.com Following a planned interim analysis the,,
2017-12-03,SPHRF,After Reaching Milestone Is STARPHARMA HOLDINGS (OTCMKTS:SPHRF)&#39;s Short Interest ... WeeklyHub The firm focuses on the,,
2017-11-30,TEVA,The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of ... Teva Pharmaceutical Industries Ltd. Marks the,,
2017-11-29,TEVA,Teva Pharma (TEVA) Announces NEJM Publishes Data from Pivotal Phase III Trial of ... StreetInsider.com “Results from the Phase III,,
2017-12-03,TILE,Jhl Capital Group Has Lowered Interface (TILE) Stake; 5 Analysts Bullish Catalyst Pharmaceuticals ... UtahHerald.com The,,
2017-12-03,TJX,Rock Point Advisors Has Increased Tjx Companies (TJX) Position By $687168; Incyte Genomics ... UtahHerald.com The companyÂ&#39;s,,
2017-11-30,VXTX,Viking Therapeutics: Buy The Rumor Buy The News Seeking Alpha Viking Therapeutics announced top-line results for its Phase II study,,
2017-11-30,VXTX,Google Meets Primary Endpoint As-it-happens update ? November 30 2017 NEWS Viking&#39;s VK5211 meets primary endpoint in phase 2 hip fracture trial Pharmaceutical Business Review Viking CEO Brian Lian,,
2017-11-29,VXTX,Viking&#39;s hip fracture treatment VK5211 meets primary endpoint in phase 2 study Pharmaceutical Business Review The top-,,
